Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 410-440-9 | CAS number: 164058-20-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 131984-21-9
- Cas Number:
- 131984-21-9
- IUPAC Name:
- 131984-21-9
- Details on test material:
- - Name of test material (as cited in study report): DIMETHYLBENZYLIDENECYCLOPENTANONE 95%
- Physical state: Solid (powder), white
- Analytical purity: 96.6%
- Lot/batch No.:COD-000462
- Storage condition of test material: Room temperature
Constituent 1
Method
- Target gene:
- X-linked hypoxanthine-guanine phosphoribosyl transferase (HGPRT) locus
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S-9 mix
- Test concentrations with justification for top dose:
- 1st experiment
without S-9 mix: 0; 0.312; 0.625; 1.25; 2.5; 5.0; 10.0; 20.0 µg/mL
with S-9 mix: 0; 0.937; 1.875; 3.75; 7.5; 15.0; 30.0; 60.0 µg/mL
2nd experiment
without S-9 mix: 0; 7.5; 10.0; 12.5; 15.0; 17.5; 20.0 µg/mL
with S-9 mix: 0; 20; 40; 60; 80; 100; 120 µg/mL - Vehicle / solvent:
- acetone
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Without metabolic activation 300 µg ethyl methane sulfonate/ mL medium; With metabolic activation (S-9 mix) 10 µg methylcholanthrene/ mL medium
- Details on test system and experimental conditions:
- Exposure period
After the attachment period of 20-24 h, the medium was replaced by fresh medium. The test article, dissolved in 200 µL acetone, was added to the culture medium:
Without S-9 mix
- 20 mL Ham's F12 medium without FCS + 200 µL acetone/test substance preparation
- 18 mL Ham's F12 medium without FCS + 2 mL positive control substance
With S-9 mnix
-16 mL Ham's F12 medium without FOS + 200 µL acetone/test substance preparation
-14 mL Ham's F12 medium without FCS + 2 mL positive control substance
plus 4 mL S-9 mix ( = 2% S-9 fraction in the 1st and 2nd experiment)
Exposure lasted over a period of 4 hours both with and without S-9 mix in an incubator (5%
CO2, 37°C and >= 90% humidity).
Expression period
After the exposure period, the serum-free medium was replaced by 20 mL Ham's F12 medium with 10% FCS after having been rinsed twice with Hanks' balanced salt solution (HBSS). The following 1st passage was carried out after an incubation period of 65 – 72 hours. After an entire expression period of 6 - 8 days the cells were transferred into selection medium (2nd passage).
Selection period
For the selection of the mutants, 6 x 300 000 cells from each treatment group were seeded in six 75 cm2 flasks with about 10 mL selection medium ("TG medium") at the end of the expression period and the flasks then returned to the incubator for about 6 - 8 days. At the end of the selection period, colonies were fixed with methanol, stained with Giemsa and counted. - Evaluation criteria:
- Acceptance criteria
The HPRT assay is considered valid if the following criteria are met:
- The absolute cloning efficiencies of the negative controls should not be less than 50% (with and without S-9 mix).
- The background mutant frequencies in the negative controls should fall within the range of
0 - 15 mutants per 10e6 clonable cells (historical negative control data listed in the Appendix of the report).
- The positive controls both with and without S-9 mix must induce significantly increased mutant frequencies (historical positive control data listed in the Appendix of the report).
- At least 4 dose levels ranging up to a toxic concentration or up to or beyond the limit of solubility under culture conditions should be tested. Freely soluble and apparently nontoxic substances are not tested at doses/concentrations higher than 5 mg/mL/ 10 mm.
Assessment criteria
A finding is assessed as positive if the following criteria are met:
- Increases of the corrected mutation frequencies both above the concurrent negative control values and the historical negative control range.
- Evidence of reproducibility of any increase in mutant frequencies.
- A statistically significant increase in mutant frequencies and the evidence of a dose-response relationship.
Isolated increases of mutant frequencies above the historical negative control range (i.e. 15 mutants per 10e6 clonable cells) or isolated statistically significant increases without a dose-response relationship may indicate a biological effect but are not regarded as sufficient evidence of mutagenicity.
The test chemical is considered non-mutagenic according to the following criteria:
- The corrected mutation frequency in all dose groups is within the historical control range and is not significantly above the concurrent negative control. - Statistics:
- Due to the clearly negative findings, a statistical evaluation was not carried out.
Results and discussion
Test results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- CYTOTOXICITY
Without S-9 mix, there was a decrease in the number of colonies (CE) and a reduced celI density at 20 µg/mL after an exposure period of 4 hours in the 1st experiment and a decrease in the number of colonies (CE) from about 12.5 µg/mL in the 2nd experiment onward but no reduced ceII density.
With S-9 mix, cytotoxic effects were not observed in the 1st experiment, but there was a deorease in the number of colonies (CE,) from about 60.0 µg/mL onward in the 2nd experiment. CeII density was not reduced.
CELL MORPHOLOGY
CeIl attachment was not influenced at any dose evaluated.
TREATMENT CONDITIONS
Osmolarity and pH values were not influenced by test substance treatment. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Mutant frequency & Cytotoxicity
1st experiment | |||||||
without S-9 mix; 4-hour exposure period | |||||||
Treatment (µg/mL) | Metabolic activation | MFuncorr (per 10e6 cells) | MFcorr (per 10e6 cells) | abs. cloning efficiency (%; survival) | rel. cloning efficiency (%, survival) | abs. cloning efficiency (%; viability) | rel. cloning efficiency (%, viability) |
vehicle control | no | 2.50 | 3.06 | 91.7 | 100.0 | 87.3 | 100.0 |
0.31 | no | 3.06 | 4.26 | 91.5 | 99.8 | 74.3 | 85.1 |
0.63 | no | 1.67 | 2.06 | 84.3 | 91.9 | 80.1 | 91.8 |
1.25 | no | 0.84 | 0.98 | 90.2 | 98.4 | 89.1 | 102.1 |
2.50 | no | 0.56 | 0.73 | 81.0 | 88.3 | 82.3 | 94.3 |
5.00 | no | 2.22 | 2.78 | 95.1 | 103.7 | 83.8 | 96.0 |
10.00 | no | 1.39 | 2.12 | 73.7 | 80.4 | 66.4 | 76.1 |
20.00 | no | 0.84 | 1.28 | 2.7 | 2.9 | 62.4 | 71.5 |
positive control | no | 59.45 | 79.36 | 95.5 | 104.1 | 75.2 | 86.1 |
withS-9 mix; 4-hour exposure period | |||||||
Treatment (µg/mL) | Metabolic activation | MFuncorr (per 10e6 cells) | MFcorr (per 10e6 cells) | abs. cloning efficiency (%; survival) | rel. cloning efficiency (%, survival) | abs. cloning efficiency (%; viability) | rel. cloning efficiency (%, viability) |
vehicle control | yes | 0.56 | 0.66 | 81.3 | 100.0 | 84.3 | 100.0 |
0.94 | yes | 0.28 | 0.33 | 70.0 | 86.1 | 80.8 | 95.8 |
1.88 | yes | 1.39 | 1.93 | 74.7 | 91.9 | 71.8 | 85.2 |
3.75 | yes | 4.45 | 4.82 | 75.8 | 93.2 | 93.4 | 110.8 |
7.50 | yes | 0.84 | 0.87 | 86.4 | 106.3 | 85.8 | 101.8 |
15.00 | yes | 0.84 | 1.02 | 87.8 | 108.0 | 86.7 | 102.8 |
30.00 | yes | 1.12 | 1.26 | 90.7 | 111.6 | 88.9 | 105.5 |
60.00 | yes | 1.95 | 2.29 | 73.2 | 90.0 | 84.8 | 100.6 |
positive control | yes | 58.61 | 72.29 | 89.0 | 109.5 | 84.8 | 100.6 |
2nd experiment | |||||||
without S-9 mix; 4-hour exposure period | |||||||
Treatment (µg/mL) | Metabolic activation | MFuncorr (per 10e6 cells) | MFcorr (per 10e6 cells) | abs. cloning efficiency (%; survival) | rel. cloning efficiency (%, survival) | abs. cloning efficiency (%; viability) | rel. cloning efficiency (%, viability) |
vehicle control | no | 0.84 | 0.92 | 84.4 | 100.0 | 89.6 | 100.0 |
7.50 | no | 0.28 | 0.40 | 88.2 | 104.5 | 69.8 | 77.8 |
10.00 | no | 0.28 | 0.34 | 73.1 | 86.6 | 82.3 | 91.9 |
12.50 | no | 0.84 | 1.32 | 66.2 | 78.4 | 61.4 | 68.5 |
15.00 | no | 0.28 | 0.45 | 23.8 | 28.2 | 62.2 | 69.4 |
17.50 | no | 0.56 | 0.74 | 10.2 | 12.1 | 70.5 | 78.7 |
20.00 | no | 1.95 | 2.94 | 0.0 | 0.0 | 66.6 | 74.3 |
positive control | no | 134.73 | 196.55 | 83.2 | 98.6 | 68.6 | 76.6 |
withS-9 mix; 4-hour exposure period | |||||||
Treatment (µg/mL) | Metabolic activation | MFuncorr (per 10e6 cells) | MFcorr (per 10e6 cells) | abs. cloning efficiency (%; survival) | rel. cloning efficiency (%, survival) | abs. cloning efficiency (%; viability) | rel. cloning efficiency (%, viability) |
vehicle control | yes | 1.67 | 2.07 | 79.7 | 100.0 | 77.2 | 100.0 |
20.00 | yes | 1.39 | 1.80 | 76.3 | 95.7 | 78.6 | 101.8 |
40.00 | yes | 1.67 | 2.48 | 68.1 | 85.4 | 66.8 | 86.5 |
60.00 | yes | 0.56 | 0.80 | 49.8 | 62.5 | 66.7 | 86.4 |
80.00 | yes | 0.56 | 0.63 | 15.9 | 19.9 | 87.2 | 113.0 |
100.00 | yes | 1.95 | 3.05 | 0.3 | 0.4 | 63.2 | 81.9 |
120.00 | yes | 1.67 | 2.18 | 0.0 | 0.0 | 69.7 | 90.3 |
positive control | yes | 94.17 | 129.43 | 68.9 | 86.4 | 71.5 | 92.6 |
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.